文献速递心脑血管急症重症综合管理与镇静镇痛

癫痫持续状态患者的死亡原因分析

Causes of Death in Status Epilepticus.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论单中心回顾性队列显示,癫痫持续状态患者院内死亡主要源于基础神经系统疾病及撤除生命支持治疗,而非麻醉药物或机械通气等治疗选择。

该研究为单中心神经科学ICU的回顾性队列,纳入2011年1月1日至2016年12月31日期间244例癫痫持续状态患者(平均年龄64岁,55%男性,中位癫痫持续状态严重程度评分3分)。院内死亡率和90天死亡率分别为9.2%和19.2%,死亡前86.3%撤除生命支持治疗、13.7%发生心脏骤停。仅癫痫持续状态严重程度评分与院内及90天死亡率相关,而麻醉药物使用、机械通气、医学并发症、病因及难治性均无关联。难治性癫痫患者出院回家可能性更低(OR 0.295,95%CI 0.143-0.608,P=0.0009)。

要点

  • 244例癫痫持续状态患者中,院内死亡率为9.2%,90天死亡率为19.2%。
  • 死亡前86.3%(19例)撤除生命支持治疗,13.7%(3例)发生心脏骤停。
  • 仅癫痫持续状态严重程度评分与院内及90天死亡率相关,麻醉药物使用、机械通气、医学并发症、病因及难治性均无关联。
  • 难治性癫痫患者出院回家可能性更低(OR 0.295,95%CI 0.143-0.608,P=0.0009)。
  • 有医学并发症、难治性癫痫及需麻醉药物控制发作者住院时间更长(P分别为0.0091、0.0077、0.0035)。

适用人群与场景

  • 单中心神经科学ICU内、2011年1月1日至2016年12月31日期间收治的癫痫持续状态患者,共244例,平均年龄64岁(四分位距42-76),55%男性。

诊断标准与关键阈值

  • 采用癫痫持续状态严重程度评分评估,中位评分为3分(四分位距2-4)。

研究设计与关键结果

  • 研究类型为回顾性队列,单中心神经科学ICU,纳入244例癫痫持续状态患者,平均年龄64岁(四分位距42-76),55%男性,中位癫痫持续状态严重程度评分3分(四分位距2-4)。
  • 24例患者接受麻醉药物输注以控制癫痫发作。
  • 院内死亡率为9.2%,90天死亡率为19.2%。
  • 死亡前86.3%(19例)撤除生命支持治疗,13.7%(3例)发生心脏骤停。
  • 多变量logistic回归显示,仅癫痫持续状态严重程度评分与院内及90天死亡率相关;麻醉药物使用、机械通气、医学并发症、病因及难治性均无关联。
  • 有医学并发症者住院时间更长(P=0.0091),难治性癫痫者更长(P=0.0077),需麻醉药物控制发作者更长(P=0.0035)。
  • 难治性癫痫患者出院回家可能性更低(OR 0.295,95%CI 0.143-0.608,P=0.0009)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究;单中心。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在该队列中死亡主要源于基础神经系统疾病和撤除生命支持治疗,而非治疗选择;麻醉药物使用、医学并发症和机械通气与院内及90天死亡率无关联。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To determine the causes of death in patients with status epilepticus. To analyze the relative contributions of seizure etiology, seizure refractoriness, use of mechanical ventilation, anesthetic drugs for seizure control, and medical complications to in-hospital and 90-day mortality, hospital length of stay, and discharge disposition.

DESIGN: Retrospective cohort.

SETTING: Single-center neuroscience ICU.

PARTICIPANTS: Patients with status epilepticus were identified by retrospective search of electronic database from January 1, 2011, to December 31, 2016.

INTERVENTIONS: Review of electronic medical records.

MEASUREMENTS AND MAIN RESULTS: Demographics, clinical characteristics, treatments, and outcomes were collected. Univariable and multivariable logistic regression analysis were used to determine whether the use of anesthetic drugs, mechanical ventilation, Status Epilepticus Severity Score, refractoriness of seizures, etiology of seizures, or medical complications were associated with in-hospital, 90-day mortality or discharge disposition. Among 244 patients with status epilepticus (mean age was 64 yr [interquartile range, 42-76], 55% male, median Status Epilepticus Severity Score 3 [interquartile range, 2-4]), 24 received anesthetic drug infusions for seizure control. In-hospital and 90-day mortality rates were 9.2% and 19.2%, respectively. Death was preceded by withdrawal of life-sustaining treatment in 19 patients (86.3%) and cardiac arrest in three (13.7%). Only Status Epilepticus Severity Score was associated with in-hospital and 90-day mortality, whereas the use of anesthetic drugs for seizure control, mechanical ventilation, medical complications, etiology, and refractoriness of seizures were not. Hospital length of stay was longer in patients with medical complications (p = 0.0091), refractory seizures (p = 0.0077), and in those who required anesthetic drugs for seizure control (p = 0.0035). Patients who had refractory seizures were less likely to be discharged home (odds ratio, 0.295; CI, 0.143-0.608; p = 0.0009).

CONCLUSIONS: In this cohort, death primarily resulted from the underlying neurologic disease and withdrawal of life-sustaining treatment and not from our treatment choices. Use of anesthetic drugs, medical complications, and mechanical ventilation were not associated with in-hospital and 90-day mortality.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Hawkes MA, English SW, Mandrekar JN, et al. Causes of Death in Status Epilepticus. Crit Care Med. 2019. PMID: 31206357. doi:10.1097/CCM.0000000000003869

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。